Victory Capital Management
MTNB icon

Victory Capital Management’s Matinas BioPharma MTNB Stock Holding History

Victory Capital Management’s Portfolio MTNB Stock Details MTNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-473
Closed -$11.8K – 2654
2022
Q4 		$11.8K Hold
473
– – ﹤0.01% 2537
2022
Q3 		$15K Sell
473
-100
-17% -$3.93K ﹤0.01% 2644
2022
Q2 		$23K Sell
573
-2
-0.3% -$76 ﹤0.01% 2602
2022
Q1 		$20K Sell
575
-16
-3% -$589 ﹤0.01% 2642
2021
Q4 		$30K Sell
591
-15
-2% -$802 ﹤0.01% 2667
2021
Q3 		$39K Sell
606
-17,807
-97% -$768K ﹤0.01% 2702
2021
Q2 		$713K Sell
18,413
-1,146
-6% -$49.3K ﹤0.01% 2023
2021
Q1 		$1.03M Sell
19,559
-850
-4% -$57K ﹤0.01% 1903
2020
Q4 		$1.39M Sell
20,409
-3,255
-14% -$151K ﹤0.01% 1636
2020
Q3 		$907K Sell
23,664
-743
-3% -$29.5K ﹤0.01% 1744
2020
Q2 		$943K Sell
24,407
-131,322
-84% -$5.04M ﹤0.01% 1756
2020
Q1 		$4.67M Buy
155,729
+128,356
+469% +$7.75M ﹤0.01% 1289
2019
Q4 		$3.11M Sell
27,373
-5,816
-18% -$337K ﹤0.01% 1348
2019
Q3 		$1.05M Buy
33,189
+490
+1% +$17.7K ﹤0.01% 1690
2019
Q2 		$1.4M Sell
32,699
-1,559
-5% -$74.9K ﹤0.01% 1231
2019
Q1 		$1.87M Buy
+34,258
New +$1.85M ﹤0.01% 1097

Other funds holding MTNB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
NRS
Neville Rodie & Shaw New York $1.55B AUM 46.95% 1-Year Est. Return
AWA
Arkadios Wealth Advisors Atlanta, Georgia $6.13B AUM 23.41% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
SCA
STALEY CAPITAL ADVISERS Pittsburgh, Pennsylvania $2.36B AUM 23.72% 1-Year Est. Return

Victory Capital Management's MTNB Position: Q1 2023 in Review

Victory Capital Management sold out of Matinas BioPharma (MTNB) in Q1 2023, closing a stake of 473 shares — an estimated $11.8K sold.

Victory Capital Management first reported a position in MTNB in Q1 2019 and held it in 16 quarters. The position peaked at $4.67M in Q1 2020. 50 funds tracked by Wall St. Rank hold MTNB as of Q1 2023.

  • Victory Capital Management reported no remaining Matinas BioPharma position as of Q1 2023 after selling out during the quarter.
  • Victory Capital Management sold 473 Matinas BioPharma shares in Q1 2023, an estimated $11.8K.
  • Victory Capital Management first reported a position in Matinas BioPharma in Q1 2019 and held it in 16 quarters.
  • Victory Capital Management's Matinas BioPharma position peaked at $4.67M in Q1 2020.
  • 50 funds tracked by Wall St. Rank held Matinas BioPharma as of Q1 2023.

Based on Victory Capital Management's 13F filing for Q1 2023, filed 2 May 2023.